Israa H. Ani
Amman, AM 11831, Jordan
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 17 publications
Bisoprolol and Amlodipine Co-Administration with Glimepiride in a Diabetic Rat Model: A Statistical and Machine Learning Analysis.
Journal: Pharmaceuticals (Basel, Switzerland)
Published: June 06, 2026
Additive Effects of Quercetin-Rich Allium cepa L. Juice and Dapagliflozin on Glycemic Variability in Streptozotocin-Induced Diabetic Rats.
Journal: Pharmaceuticals (Basel, Switzerland)
Published: June 04, 2026
Anticancer Activity of Alectinib through Hydroxypropyl-β-Cyclodextrin Complexation: In Vitro Evaluation on A549 Lung Cancer Cells.
Journal: Drug research
Published: December 29, 2025
Novel Anticancer Triple Formula Based on Aptamer-Conjugated PEGylated Nanoliposomes.
Journal: Technology in cancer research & treatment
Published: July 03, 2025
In Vitro and In Vivo Evaluation of Alectinib-Loaded Dendrimer Nanoparticles as a Drug Delivery System for Non-Small Cell Lung Carcinoma.
Journal: Pharmaceutics
Published: April 19, 2025
Design of Experiment Approach for Enhancing the Dissolution Profile and Robustness of Loratadine Tablet Using D-α-Tocopheryl Polyethylene Glycol 1000 Succinate.
Journal: Pharmaceutics
Published: February 14, 2025
Circadian rhythms and cancer: implications for timing in therapy.
Journal: Discover oncology
Published: September 01, 2024
Preparation and Evaluation of Complexed Ubiquinone (Coenzyme Q10) Antiaging Hyaluronic Acid-Vitamin C Serum for Skin Care.
Journal: Journal of cosmetic dermatology
Published: August 26, 2024
Development and Evaluation of a Cost-Effective, Carbon-Based, Extended-Release Febuxostat Tablet.
Journal: Molecules (Basel, Switzerland)
Published: August 23, 2024
Solubility, pH-Solubility Profile, pH-Rate Profile, and Kinetic Stability of the Tyrosine Kinase Inhibitor, Alectinib.
Journal: Pharmaceuticals (Basel, Switzerland)
Published: May 11, 2024
Evaluation of Solubility, Dissolution Rate, and Oral Bioavailability of β-Cyclodextrin and Hydroxypropyl β-Cyclodextrin as Inclusion Complexes of the Tyrosine Kinase Inhibitor, Alectinib.
Journal: Pharmaceuticals (Basel, Switzerland)
Published: April 30, 2024
Last Updated: 09/26/2026